4
Changes in Ownership
ATOSSA THERAPEUTICS, INC. Filed Acc 0001615774-18-004655
Options or other derivatives
- CFO, Gen Counsel and Secretary bought 2,280 shares at $1,000.00 ($2,280,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Guse Kyle CFO, Gen Counsel and Secretary | 2018-05-30 | Purchase · Series B Convertible Preferred Stock | +8 | $1,000.00 | $8,000 | 8 | D |
| Guse Kyle CFO, Gen Counsel and Secretary | 2018-05-30 | Purchase · Warrants | +2,272 | $1,000.00 | $2,272,000 | 2,272 | D |
Loading xslF345X03/s110545_form4.xml…